Teriparatide

Teriparatide (Zyntex) is a recombinant human parathyroid hormone (1-34) used in the treatment of osteoporosis by stimulating new bone formation and increasing bone mineral density.

SKU: 52232-67-4 Category: Tag:
Description
Teriparatide is a synthetic polypeptide consisting of the first 34 amino acids of the human parathyroid hormone. Zyntex supplies this premium active pharmaceutical ingredient for the global metabolic bone disease and specialized orthopedic sectors. This high-purity peptide (CAS 52232-67-4) is the only class of osteoporosis medication that is anabolic, meaning it builds new bone rather than just preventing bone loss. It acts as a primary agent by activating osteoblasts through the PTH receptor. In addition, it significantly reduces the risk of vertebral and non-vertebral fractures. Therefore, manufacturers choose Teriparatide for high-end injectable pens and advanced drug delivery systems.

Teriparatide Product Overview

Maximum bone-building efficacy provides a major advantage in geriatric medicine. Teriparatide effectively restores bone architecture in patients with severe osteoporosis or those who have failed traditional bisphosphonate therapy. This feature makes it a breakthrough treatment for postmenopausal women and men at high risk of fracture. For instance, daily subcutaneous administration triggers a rapid increase in bone mineral density (BMD) in the spine and hip. Consequently, it supports improved quality of life for aging populations. As a result, Zyntex produces Teriparatide with exceptional recombinant purity, ensuring total stability in temperature-sensitive liquid formulations.

Moreover, Zyntex provides research-grade peptides for advanced studies in mineral metabolism and fracture healing. This application allows for the study of intermittent PTH signaling on skeletal integrity. It pushes the boundaries of modern regenerative medicine. At the same time, pharmaceutical formulators value its role in developing biosimilar therapies that increase global access to bone-forming drugs. In short, our product serves as a dependable “anabolic bone agent.” It supports both the retail pharmaceutical market and specialized clinical research in orthopedics. Recently, interest in Teriparatide for dental implant osseointegration has grown, highlighting its expanding therapeutic potential.

Teriparatide Key Applications

This high-performance anabolic peptide is vital in these four specialized sectors:

🦴 Osteoporosis Therapy

It is the primary active for bone-building. Thus, it provides consistent results for treating severe vertebral bone loss.

🏗️ Orthopedic Surgery

It serves as a key agent for fracture non-union. Consequently, it helps accelerate bone healing in complex clinical cases.

🧪 Endocrinology R&D

It works as a key tool for PTH receptor research. Undoubtedly, it is essential for studying calcium and phosphate homeostasis.

🔬 Biosimilar Production

It acts as a primary active for follow-on biologics. Specifically, it aids in formulating cost-effective metabolic bone treatments.

Technical Specifications

ParameterStandard Value
Product NameTeriparatide
Purity (HPLC)≥ 99.0%
Molecular FormulaC181H291N55O51S2
CAS Number52232-67-4

⚠️ Usage Note: Teriparatide must be stored under strict refrigeration ($2°C$ to $8°C$) and protected from light. Therefore, handle with professional care and ensure the cold chain is maintained from manufacture to clinical application to prevent bio-inactivation.